Analgesics in Latvia
ANALGESICS IN LATVIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Self-medication Continues To Grow
Topical Analgesics/anaesthetic Performs Well
Ibuprofen Remains by Far the Most Popular Systemic Analgesic
Competitive Landscape
Nycomed Pharma As Maintains the Leading Spot
Private Label Struggles To Find Its Place in Analgesics
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Latvia Remains A Lucrative Market for New Products
Self-medication Remains the Main Growth Driver
Brands With Strong Advertisement Support Have Great Advantage
Pharmacy Chains Dictate Product Choices
Consolidation Versus Natural Products
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Sources
Summary 1 Research Sources
The number of consumers that self-medicate grew as analgesics continued to be one of the largest OTC categories in terms of value sales. Self-medication plays an important role in Latvian healthcare for several reasons. For minor illnesses, self-medication with analgesics often provides a cheap, rapid and convenient solution for consumers feeling unwell. Consumers also self-medicate to get rid of pain as many consumers have difficulty seeking medical professional help due to issues in the Latvia...
Euromonitor International's Analgesics in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.